Additional antihemophilic factor to be available.
Thompson
Cheryl A
CA
D017277:Drug Approval; D005169:Factor VIII / Q000009:adverse effects / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D019106:Postoperative Hemorrhage / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012709:Serum Albumin / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration
D011994:Recombinant Proteins; D012709:Serum Albumin; C078147:F8 protein, human; D005169:Factor VIII